The US FDA clearance will enable to take the our offering to the US – which is the largest global healthcare market
DeepTek.ai, a leading radiology AI company, has made a significant breakthrough with its AI-powered Radiology Workflow Management Solution, Augmento. This platform has received 510(k) clearance from the US Food and Drug Administration (FDA) for clinical use, making it a reliable choice for healthcare providers around the world.
Dr Amit Kharat, Co-Founder and CEO, DeepTek.ai expressed his thoughts saying, “The US FDA clearance is a big shot in our arm. It enables us to take our offering to the US – which is the largest global healthcare market. At DeepTek our vision is to revolutionise radiology with the power of AI and make it more affordable, accessible, and accurate.”
“AI in healthcare is in a very early phase. AI results are still opaque/black box in nature and hence doctors are not quite comfortable relying on them. ‘Responsible AI’ addresses these issues and brings techniques to enable building trust between the Doctors and the AI results. DeepTek has been working at the forefront of this technology,” said Ashutosh Pathak, Chief Technology Officer, DeepTek.ai.
